ABVC
ABVC
NASDAQ · Biotechnology

Abvc Biopharma Inc

$1.74
+0.14 (+8.75%)
As of Feb 8, 2:19 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 10.04M 9.21M 8.21M
Net Income 1.01M 1.19M 806.0K
EPS
Profit Margin 10.1% 12.9% 9.8%
Rev Growth +21.1% -0.3% +20.3%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 17.61M 16.13M 16.68M
Total Equity 17.65M 18.59M 19.29M
D/E Ratio 1.00 0.87 0.86
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.65M 1.73M 1.63M
Free Cash Flow 1.05M 900.3K 756.9K